Induced Pluripotent Stem Cells and Gene Editing: A Transformative Era in Regenerative Medicine
International Journal of Drug Delivery Technology · 29.05.2026 · 16 (5)
DOI: 10.25258/ijddt.16.5.136 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 29.05.2026. Verfasst von Sujitha Mathivanan und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Induced pluripotent stem cell (iPSC) technology and genome editing have independently transformed regenerative medicine, and their convergence now defines a powerful platform for disease modelling and cell-based therapy. iPSCs provide an ethically acceptable, patient-specific source of pluripotent cells, while genome-editing toolsparticularly CRISPR–Cas systems, base editors, and prime editors enable precise genetic modification of disease-relevant loci. This critical review examines recent advances at the interface of iPSC biology and gene editing, emphasising mechanistic integration, translational feasibility, and clinical decision-making. Key challengesincluding incomplete epigenetic reprogramming, genomic instability, off-target editing, immune recognition, and Good Manufacturing Practice (GMP) scalabilityare systematically evaluated. We further analyse why only select iPSC-derived therapies, notably in retinal and haematologic indications, have advanced to clinical trials, highlighting biological, manufacturing, and regulatory constraints. By integrating biological mechanisms with translational bottlenecks and ethical considerations, this review provides a structured framework for assessing the clinical potential of genomeedited iPSC technologies in precision regenerative medicine.
Zitieren
APA
Mathivanan, S., A, B., S, S. M. O., Babu, H., S, S., & D, T. (2026). Induced Pluripotent Stem Cells and Gene Editing: A Transformative Era in Regenerative Medicine. International Journal of Drug Delivery Technology, 16(5). https://doi.org/10.25258/ijddt.16.5.136
Vancouver
Mathivanan S, A B, S SMO, Babu H, S S, D T. Induced Pluripotent Stem Cells and Gene Editing: A Transformative Era in Regenerative Medicine. International Journal of Drug Delivery Technology. 2026;16(5). doi:10.25258/ijddt.16.5.136
BibTeX
@article{Mathivanan2026,
author = {Mathivanan, Sujitha and A, Balaji and S, Syed Mohamed Omar and Babu, Harish and S, Sujan and D, Thilan},
title = {Induced Pluripotent Stem Cells and Gene Editing: A Transformative Era in Regenerative Medicine},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {5},
doi = {10.25258/ijddt.16.5.136}
}
EUVIMED